-

Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology

Precision in Every Drop: The New MOVE-T Liquid Dairy Analyzer for Enhanced Quality Control

ETTLINGEN, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the MOVE-T, a state-of-the-art liquid dairy analyzer designed to elevate quality control standards in the dairy industry. Utilizing advanced Fourier Transform Near-Infrared (FT-NIR) technology, the MOVE-T provides unparalleled precision analyzing raw milk and other liquid dairy products, ensuring superior product quality and consistency.

Tailored for the dairy industry and sectors processing liquid dairy products or plant-based drinks, it provides a robust tool for enhancing product quality and operational efficiency. The integration of FT-NIR technology with a wear-free quartz cell ensures high sensitivity, specificity, and transferability, making the MOVE-T an indispensable asset for modern dairy quality control. By leveraging the superior stability of FT-NIR technology over time and across instruments, the analyzer delivers precise and reliable results in accordance with ISO 21543 (IDF 201), setting a new benchmark in liquid dairy analysis and empowering producers to maintain consistent product quality.

Katharina Baumgartner, Dairy Laboratory Specialist and long-time user of FT-NIR technology for milk analysis instruments at GOLDSTEIG Cheese Factories Bayerwald GmbH, commented: "We are thrilled with the new MOVE-T. The compact and integrated design seamlessly fits into our workflow. The transferability of methods is exceptionally good, as are the results for our key products in quality control. We are very excited about the market launch of the MOVE-T."

Dr. Jörg-Peter Conzen, Vice-President of Bruker Optics, added, "The MOVE-T reflects our dedication and our commitment to innovation and analytical excellence. By providing the dairy industry with cutting-edge NIR technology, we are helping our customers achieve greater efficiency and product consistency. This launch completes our proven portfolio of dairy FT-NIR analyzers for lab and process control."

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nano analysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Contacts

Media Contact:
Natalie Spahl
Head of Global Marketing
Bruker Optics Division
T: +49 173 9662425
E: Natalie.spahl@bruker.com

Investor Contact:
Joe Kostka
Director, Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

Bruker Corporation

NASDAQ:BRKR

Release Versions
$Cashtags
Hashtags

Contacts

Media Contact:
Natalie Spahl
Head of Global Marketing
Bruker Optics Division
T: +49 173 9662425
E: Natalie.spahl@bruker.com

Investor Contact:
Joe Kostka
Director, Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

Social Media Profiles
More News From Bruker Corporation

RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--RI Research Instruments, a company that is majority-owned by Bruker Corporation (Nasdaq: BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of the Extreme Light Infrastructure – Nuclear Physics (ELI-NP) at the Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH) in Romania. The total value of these ELI contracts is approximately €35 million (more than USD $40 million), w...

Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions

ETTLINGEN, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: In the summer, École Normale Supérieure (ENS-PSL) in Paris, France ordered a novel NMR relaxometry system to be used alongside its recently acquired 900 MHz NMR spectrometer. This unique capability will empower the investigation of the molecular dynamics of protei...

Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1st, 2026. Mr. Phillips is a senior healthcare industry executive with over 30 years of leadership experience in the diagnostics industry. Frank H. Laukien, chairman, president and CEO of Bruker Corporation, stated: “Bruker is delighted to add Jack to our board of directors. His broad and deep diag...
Back to Newsroom